F-4XYRATEX LTDAUDITED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY AND COMPREHENSIVE INCOME (LOSS)(US dollars and amounts, in thousands)<strong>Xyratex</strong> Group Limited<strong>Xyratex</strong> Group<strong>Xyratex</strong> LtdLimitedNumber ofAccumulatedNumber ofOrdinary Shares<strong>Xyratex</strong> Ltd Par valueAdditional otherCommon paid in Accumulated comprehensive TreasuryShares A B C Treasury Par value A B C capital deficit income (loss) shares TotalBalances as of November 30, 2002 ............. — 7,166 1,856 12,850 $ — $ 106 $ 27 $ 200 $ 11,265 $ (3,299) $ 663 $ 8,962Conversion of ordinary shares(1) ............. 2,416 10,434 (12,850) $ 38 $ 162 $(200) —Repurchase of ordinary shares(1) ............. (2,661) (18,939) —Retirement of ordinary shares(1) ............. (805) (1,856) 2,661 (12) (30) 42 (18,939) 18,939 (18,939)Issuance of ordinary shares ................. 68 665 1 10 4,944 4,955Non cash equity compensation ............... 77,201 77,201Employee bonus paid by trust ............... 1,573 1,573Components of comprehensive loss, net of tax: ..... —Net loss ............................ (56,194)Unrealized gain on forward foreign currency contractsnet of reclassification adjustment: ............ 1,443Total comprehensive loss .................. (54,751)Balances as of November 30, 2003 ............. — 8,845 11,099 — — $ — $ 133 $ 169 $ 0 $ 95,025 $ (78,432) $ 2,106 $ — $ 19,001Issuance of <strong>Xyratex</strong> Group Limited ordinary shares . . . 1,412 2,576 26 47 4,182 4,255Exchange of <strong>Xyratex</strong> Group Limited ordinary shares for<strong>Xyratex</strong> Ltd common shares(2) ............. 23,880 (10,257) (11,099) (2,576) 239 (159) (169) (47) 136 —Issuance of <strong>Xyratex</strong> Ltd common shares ......... 4,163 41 48,851 48,892Non-cash equity compensation ............... 181,073 181,073Components of comprehensive loss, net of tax:Net loss ............................ (135,169)Unrealized gain on forward foreign currency contractsnet of reclassification adjustment: ............ (1,351)Total comprehensive loss .................. (136,520)Balances as of November 30, 2004 ............. 28,043 — — — — $280 $ — $ — $ — $329,267 $(213,601) $ 755 $ — $ 116,701Issuance of common shares ................. 394 4 2,171 2,175Non-cash equity compensation ............... 2,304 2,304Employee bonus paid by trust ............... 144 144Components of comprehensive income, net of tax:Net income .......................... 42,169Unrealized loss on forward foreign currency contractsnet of reclassification adjustment: ............ (2,111)Total comprehensive income ................ 40,058Balances as of November 30, 2005 ............. 28,437 — — — — $284 $ — $ — $ — $333,886 $(171,432) $(1,356) $ — $ 161,382(1) All existing class A, B and C ordinary shares were converted to class A preferred ordinary shares on September 17, 2003. 2,661 of these shares were repurchased by the Company and retired and10,434 of these shares were purchased directly from shareholders by HgCapital with the remainder being retained by existing shareholders. The 10,434 shares which HgCapital acquired wereconverted to class B preferred ordinary shares. The overall effects of these purchases, retirements and conversions is shown on the lines entitled ‘‘Repurchase of ordinary shares’’, ‘‘Retirement ofordinary shares’’ and ‘‘Conversion of ordinary shares’’.(2) As part of the scheme of arrangement and in connection with the IPO, the Company’s shareholders exchanged 10,257 class A preferred ordinary shares, 11,099 class B preferred ordinary sharesand 2,576 class C ordinary shares in <strong>Xyratex</strong> Group Limited in the ratios 1.036378, 0.945 and 1.071671 respectively, for 23,880 common shares in <strong>Xyratex</strong> Ltd.The accompanying notes are an integral part of these consolidated financial statements.
XYRATEX LTDAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWSYear Ended November 30,2005 2004 2003(US dollars in thousands)(revised)(1)Cash flows from operating activities:Net income (loss) from continuing operations .................... $41,889 $(122,245) $(35,815)Adjustments to reconcile net income (loss) from continuing operations tonet cash provided by operating activities:Depreciation ........................................... 6,694 5,336 4,969Amortization of intangible assets ............................. 3,218 1,169 —Non-cash equity compensation ............................... 828 168,149 57,261Bonus paid by trust ....................................... 144 — 1,573In process research and development .......................... 3,230 852 —Private equity and restructuring costs .......................... — — 4,682Loss (gain) on sale of assets ................................ 90 (36) 71Supplier note receivable ................................... — (6,000) —Changes in assets and liabilities, net of impact of acquisitions anddivestituresAccounts receivable ..................................... (29,272) (6,695) (7,820)Inventories ........................................... (16,297) (2,084) (9,832)Prepaid expenses and other current assets ..................... (542) 244 (947)Accounts payable ....................................... 25,668 4,251 5,208Customer advance ...................................... — (1,073) (1,227)Employee compensation and benefits payable ................... 2,474 (1,610) 4,837Deferred revenue ...................................... (2,560) (11,093) 9,209Income taxes payable .................................... (643) 147 (1,479)Deferred income taxes ................................... 4,403 (7,709) (13,538)Amount payable to related party ............................ — — (1,342)Other accrued liabilities .................................. (986) 1,234 3,951Net cash used for operating activities of discontinued operations ..... 280 — (780)Net cash provided by operating activities .................... 38,618 22,837 18,981Cash flows from investing activities:Investments in property, plant and equipment .................. (17,070) (8,985) (5,107)Dispositions of property, plant and equipment .................. — 36 —Disposal of business, net of cash disposed and costs of disposition .... — — (175)Acquisition of business, net of cash received .................... (34,845) (7,418) —Repayment of supplier note receivable ........................ — 6,000 —Net cash used in investing activities ........................ (51,915) (10,367) (5,282)Cash flows from financing activities:Net payments of short-term borrowings ....................... (9,133) (4,133) (4,630)Payment of acquisition note payable ......................... (2,000) — —Proceeds of long term borrowing ............................ — — 19,000Payments of long term borrowing ........................... — — (7,850)Repurchase of ordinary shares ............................. — — (18,939)Proceeds from issuance of shares ........................... 2,175 53,150 273Net cash provided by (used in) financing activities .............. (8,958) 49,017 (12,146)Change in cash and cash equivalents ........................... (22,255) 61,487 1,553Cash and cash equivalents at beginning of period—continuing operations . 63,495 2,008 455Cash and cash equivalents at end of period—continuing operations ..... $41,240 $ 63,495 $ 2,008(1) We have revised our 2003 statement of cash flows to disclose that cash flows attributable to ourdiscontinued operations relate to operating activities.The accomanying notes are an integral part of these consolidated financial statements.F-5
- Page 3:
XYRATEX LTDANNUAL REPORT FOR THE YE
- Page 6 and 7:
INTRODUCTIONWe are incorporated und
- Page 8 and 9:
Year Ended November 30,2005 2004 20
- Page 10 and 11:
The computations for the weighted a
- Page 12 and 13:
The markets in which we operate are
- Page 14 and 15:
technological capabilities. This co
- Page 16 and 17:
may cease production of components,
- Page 18 and 19:
• potentially adverse tax consequ
- Page 20 and 21:
We could incur substantial costs, i
- Page 22 and 23:
influence by voting at a meeting of
- Page 24 and 25:
Xyratex Ltd to the former sharehold
- Page 26 and 27:
In addition to the rapid growth of
- Page 28 and 29:
RAID controller technology is proje
- Page 30 and 31:
Our Competitive StrengthsDisk drive
- Page 32 and 33:
the storage subsystem and disk driv
- Page 34 and 35:
Our storage subsystems are internal
- Page 36 and 37:
systems are capable of testing a fu
- Page 38 and 39:
Research and DevelopmentWe have ove
- Page 40 and 41:
• sets forth procedures for the p
- Page 42 and 43:
Item 4C: Organization StructureXyra
- Page 44 and 45: ecame the parent company of our bus
- Page 46 and 47: Foreign Exchange Rate FluctuationsT
- Page 48 and 49: we recorded in the year ended Novem
- Page 50 and 51: Fiscal Year Ended November 30, 2005
- Page 52 and 53: Research and Development—otherThe
- Page 54 and 55: Fiscal Year Ended November 30, 2004
- Page 56 and 57: Selling, General and Administrative
- Page 58 and 59: Quarterly Results of OperationsThe
- Page 60 and 61: sales growth. The increase in defer
- Page 62 and 63: choose to make or alliances we have
- Page 64 and 65: compete. Identifiable intangible as
- Page 66 and 67: ITEM 6: DIRECTORS, SENIOR MANAGEMEN
- Page 68 and 69: Ernest Sampias has served as a dire
- Page 70 and 71: Audit CommitteeOur Audit Committee
- Page 72 and 73: Employee Benefit/Share Option Plans
- Page 74 and 75: The maximum amount that any partici
- Page 76 and 77: Restricted StockRestricted stock aw
- Page 78 and 79: the options, warrants or rights, bu
- Page 80 and 81: Quarterly high and low market price
- Page 82 and 83: whose functional currency is not th
- Page 84 and 85: on the Nasdaq National Market and,
- Page 86 and 87: Interest RatesWe had cash and cash
- Page 88 and 89: aggregate in any fiscal year and th
- Page 90 and 91: (This page has been left blank inte
- Page 92 and 93: XYRATEX LTDAUDITED CONSOLIDATED BAL
- Page 96 and 97: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 98 and 99: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 100 and 101: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 102 and 103: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 104 and 105: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 106 and 107: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 108 and 109: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 110 and 111: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 112 and 113: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 114 and 115: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 116 and 117: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 118 and 119: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 120 and 121: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 122 and 123: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 124 and 125: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 126 and 127: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 128 and 129: XYRATEX LTDNOTES TO AUDITED CONSOLI
- Page 130: (This page has been left blank inte